BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31330078)

  • 21. Effect of inhibition of interleukin-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages.
    Voloshyna I; Mounessa J; Carsons SE; Reiss AB
    Clin Exp Dermatol; 2016 Apr; 41(3):308-11. PubMed ID: 26095599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of expression pattern of selected genes associated with IL12/23 signaling paths in psoriatic patients during cyclosporine A therapy.
    Grabarek BO; Wcisło-Dziadecka D; Michalska-Bańkowska A; Gola J
    Dermatol Ther; 2019 Nov; 32(6):e13129. PubMed ID: 31631469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain.
    Zhang L; Badgwell DB; Bevers JJ; Schlessinger K; Murray PJ; Levy DE; Watowich SS
    Mol Cell Biochem; 2006 Aug; 288(1-2):179-89. PubMed ID: 16718380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tumor necrosis factor-α, interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis.
    Takamura S; Takahashi A; Inoue Y; Teraki Y
    J Dermatol; 2018 Sep; 45(9):1130-1134. PubMed ID: 30004583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The
    Hagberg N; Joelsson M; Leonard D; Reid S; Eloranta ML; Mo J; Nilsson MK; Syvänen AC; Bryceson YT; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1070-1077. PubMed ID: 29475858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus.
    Li J; Zhao S; Yi M; Hu X; Li J; Xie H; Zhu W; Chen M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):109-15. PubMed ID: 21368418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
    Bissonnette R; Nigen S; Langley RG; Lynde CW; Tan J; Fuentes-Duculan J; Krueger JG
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1298-305. PubMed ID: 24112799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J.
    Robinson K; Vona-Davis L; Riggs D; Jackson B; McFadden D
    J Am Coll Surg; 2006 May; 202(5):788-96. PubMed ID: 16648019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study.
    Blauvelt A; Reich K; Mehlis S; Vanaclocha F; Sofen H; Abramovits W; Zhao Y; Gilloteau I; Davenport E; Williams N; Guana A; Tyring S
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1693-1699. PubMed ID: 28602039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of
    Sobolev V; Nesterova A; Soboleva A; Mezentsev A; Dvoriankova E; Piruzyan A; Denisova E; Melnichenko O; Korsunskaya I
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells.
    Miyagi T; Gil MP; Wang X; Louten J; Chu WM; Biron CA
    J Exp Med; 2007 Oct; 204(10):2383-96. PubMed ID: 17846149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.
    Andrés RM; Hald A; Johansen C; Kragballe K; Iversen L
    Exp Dermatol; 2013 May; 22(5):323-8. PubMed ID: 23614738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis.
    Chiu HY; Wang TS; Chan CC; Cheng YP; Lin SJ; Tsai TF
    Br J Dermatol; 2014 Nov; 171(5):1181-8. PubMed ID: 24734995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total glucosides of paeony attenuates animal psoriasis induced inflammatory response through inhibiting STAT1 and STAT3 phosphorylation.
    Li B; He S; Liu R; Huang L; Liu G; Wang R; Yang Z; Liu X; Leng Y; Liu D; Ye C; Li Y; Chen Y; Yin H; Fang W
    J Ethnopharmacol; 2019 Oct; 243():112121. PubMed ID: 31356966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Let-7a Inhibits T-Cell Proliferation and IFN-γ Secretion by Down-Regulating STAT3 Expression in Patients with Psoriasis.
    Hu XP; Xie Q; Chen CF; Zhang W; Yu B
    Cell Physiol Biochem; 2017; 42(1):115-125. PubMed ID: 28494466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of ATRAP in adipocytes and negative regulation by beta-adrenergic stimulation of JAK/STAT.
    Westphal S; Perwitz N; Iwen KA; Kraus D; Schick R; Fasshauer M; Klein J
    Horm Metab Res; 2008 Mar; 40(3):165-71. PubMed ID: 18236361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
    Arakawa A; Ruzicka T; Prinz JC
    JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two-Week, Prospective, Open-Label Feasibility Study.
    Savage L; Goodfield M; Horton L; Watad A; Hensor E; Emery P; Wakefield R; Wittmann M; McGonagle D
    Arthritis Rheumatol; 2019 Apr; 71(4):626-631. PubMed ID: 30468001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis.
    De Wilde K; Martens A; Lambrecht S; Jacques P; Drennan MB; Debusschere K; Govindarajan S; Coudenys J; Verheugen E; Windels F; Catrysse L; Lories R; McGonagle D; Beyaert R; van Loo G; Elewaut D
    Ann Rheum Dis; 2017 Mar; 76(3):585-592. PubMed ID: 27551052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.